Caption Management’s Intercept Pharmaceuticals, Inc. ICPT Stock Holding History

Caption Management’s Portfolio ICPT Stock Details ICPT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-208,000	Closed	-$2.9M	–	1841
2022 Q3	$2.9M	Buy	+208,000	New	+$3.35M	0.04%	514
2022 Q2	–	Sell	-110,600	Closed	-$1.8M	–	1954
2022 Q1	$1.8M	Buy	110,600 +88,000	+389%	+$1.38M	0.02%	787
2021 Q4	$368K	Buy	+22,600	New	+$381K	﹤0.01%	1320
2019 Q4	–	Sell	-16,000	Closed	-$1.06M	–	1041
2019 Q3	$1.06M	Buy	+16,000	New	+$1.07M	0.06%	367
2019 Q2	–	Sell	-34,900	Closed	-$3.9M	–	871
2019 Q1	$3.9M	Buy	+34,900	New	+$3.81M	0.22%	137

Other funds holding ICPT

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return

EAM

Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Caption Management's ICPT Position: Q4 2022 in Review

Caption Management sold out of Intercept Pharmaceuticals, Inc. (ICPT) in Q4 2022, closing a stake of 86,859 shares — an estimated $1.21M sold.

Caption Management first reported a position in ICPT in Q4 2019 and held it in 7 quarters. The position peaked at $4.28M in Q4 2019. 144 funds tracked by Wall St. Rank hold ICPT as of Q4 2022.

Caption Management reported no remaining Intercept Pharmaceuticals, Inc. position as of Q4 2022 after selling out during the quarter.
Caption Management sold 86,859 Intercept Pharmaceuticals, Inc. shares in Q4 2022, an estimated $1.21M.
Caption Management first reported a position in Intercept Pharmaceuticals, Inc. in Q4 2019 and held it in 7 quarters.
Caption Management's Intercept Pharmaceuticals, Inc. position peaked at $4.28M in Q4 2019.
144 funds tracked by Wall St. Rank held Intercept Pharmaceuticals, Inc. as of Q4 2022.

Based on Caption Management's 13F filing for Q4 2022, filed 14 Feb 2023.